Novogene Co Ltd
688315
Company Profile
Business description
Novogene Co Ltd is engaged in providing multi-level scientific research and technical services and solutions for life science basic research, medical and clinical application research, and independent development and innovation of genetic testing medical equipment.
Contact
No. 29, Shengshengyuan Road
Room B258, Innovation Building
Huilongguan Town, Changping District
Beijing100015
CHNT: +86 1082837801
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
2,225
Stocks News & Analysis
stocks
Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?
From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.
stocks
ASX energy share remains cheap despite strong outlook
Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.
stocks
Moated AI-proof tech play hiding in the ASX 100
ChatGPT and large language models should be a tailwind for this company.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,990.80 | 20.60 | 0.23% |
| CAC 40 | 8,158.39 | 0.57 | 0.01% |
| DAX 40 | 24,137.90 | 8.92 | 0.04% |
| Dow JONES (US) | 49,207.47 | 23.24 | -0.05% |
| FTSE 100 | 10,352.22 | 26.86 | -0.26% |
| HKSE | 25,925.65 | 52.42 | -0.20% |
| NASDAQ | 24,771.59 | 65.01 | -0.26% |
| Nikkei 225 | 60,537.36 | 821.18 | 1.38% |
| NZX 50 Index | 12,874.94 | 9.99 | -0.08% |
| S&P 500 | 7,161.03 | 4.05 | -0.06% |
| S&P/ASX 200 | 8,766.40 | 17.20 | 0.20% |
| SSE Composite Index | 4,086.34 | 6.44 | 0.16% |